Pathway Genomics Stock

pathway.comHealthcare / BioTech & PharmaFounded: 2008Funding to Date: $127.23MM

Pathway Genomics is a biotechnology company focused on providing users with the most validated and personalized healthcare information delivered to any device, the company’s program with IBM Watson is the first of its kind to merge artificial intelligence and deep learning with precision medicine, applicable to both consumers and providers.

Register To Buy and Sell Shares

For more details on financing and valuation for Pathway Genomics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Pathway Genomics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Pathway Genomics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Pathway Genomics investors also invested in these private companies

International Business Machines

Team

Management Team

Kamal Adawi
CFO
K'Lene Oen
Chief Business Officer
Nilesh Dharajiya MD
Chief Laboratory Officer & Medical Director
James Plante
Founder, Board Member, CEO
Glenn Braunstein MD
Chief Medical Officer
Anja Kammesheidt Ph.D
Chief Scientific Officer
Michael Nova Ph.D
Chief Innovation Officer

Board Members

Christopher Kitching
Mark Sopp
Pathway Genomics
Peter Leddy Ph.D
Peter Pace

News Highlights

Prostate Biopsy Market Size, Application,Revenue, Types, Trends in Future, Scope to 2021 - TokensJournal
The Prostate Biopsy Market  report  provides valuable and unique information which is very  essential. Further it also covers key players,application and future market condition.This information is extremely useful information for new and growing  company to mark themself over the market Prostate Biopsy market to grow at a CAGR OF 12.66% during the period 2017-2021. This …
Direct-To-Consumer Genetic Testing Market with top 20 Countries data Forecast to 2022 with Global Key Companies Profile, Supply, Demand, Cost Structure and Growth Factors - TokensJournal
Direct-To-Consumer Genetic Testing Market Report cover detailed competitive outlook including the Direct-To-Consumer Genetic Testing Industry share and company profiles of the key participants operating in the global market. The Direct-To-Consumer Genetic Testing market report provides an in-depth overview of Product Specification, technology, product type and production analysis considering major factors such as Revenue, Cost, Gross and …
Direct-to-consumer Genetic Testing Market Analysis, Overview, Growth, Demand and Forecast Research Report to 2023 - BitsEther
Direct-to-consumer Genetic Testing Market Research highlights key dynamics of Global Direct-to-consumer Genetic Testing Industry sector. The potential of the Direct-to-consumer Genetic Testing Market has been investigated along with the key challenges. The current Direct-to-consumer Genetic Testing Market scenario and future prospects of the sector has also been studied. Market Report provides additional information like Sales Channel, Distributors, Traders …
Updated on: Apr 17, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.